Revival Earns Esteemed GCSA Certification, Uplifting Clinical Research Standards!

May 6th, 2024, Michigan — With immense pride, Revival is delighted to declare its recent accomplishment, the prestigious certification by the Global Quality Standard for Clinical Research Sites (GCSA). This significant achievement highlights Revival Research Institute’s continuous dedication to upholding the highest global standards in operational processes for clinical research.

The GCSA program stands as a globally recognized benchmark for quality in clinical research. Revival achieved the Global Clinical Site Accreditation Certification by fulfilling the rigorous standards established by the GCSA, guaranteeing adherence to Good Clinical Practice (GCP) guidelines.

Key elements contributing to Revival’s successful attainment of the GCSA Certification include:

• Rigorous Data Quality: Robust processes being carried out at Revival, ensuring accuracy & integrity of clinical trial data.
• Experienced & Qualified Personnel: Revival comprising a team of highly trained and experienced research professionals.
• Commitment to Continuous Improvement: Identifying areas for continuous improvement to optimize site performance.
• Minimal Protocol Deviations: Proactive measures to minimize protocol deviations as per regulatory requirements.

About Revival Research Institute, LLC

Revival Research Institute, LLC, is a leading clinical research organization dedicated to pushing the boundaries of knowledge and innovation within the clinical research arena. Committed to excellence, the organization leverages interdisciplinary approaches through clinical trials to address various health challenges. Our mission is to provide pharmaceuticals and CROs access to high-quality data while offering compassionate care to participants involved in our trials.